Toll Free: 1-888-928-9744

Post-Operative Pain - Pipeline Review, H2 2016

Published: Jul, 2016 | Pages: 187 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Post-Operative Pain - Pipeline Review, H2 2016

Summary

Global Markets Direct's, 'Post-Operative Pain - Pipeline Review, H2 2016', provides an overview of the Post-Operative Pain pipeline landscape. 

The report provides comprehensive information on the therapeutics under development for Post-Operative Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Post-Operative Pain and features dormant and discontinued projects. 

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Post-Operative Pain
- The report reviews pipeline therapeutics for Post-Operative Pain by companies and universities/research institutes based on information derived from company and industry-specific sources 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report reviews key players involved Post-Operative Pain therapeutics and enlists all their major and minor projects
- The report assesses Post-Operative Pain therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report summarizes all the dormant and discontinued pipeline projects 
- The report reviews latest news related to pipeline therapeutics for Post-Operative Pain

Reasons To Buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Post-Operative Pain
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies 
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Post-Operative Pain pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
 Table of Contents
Table of Contents 2 List of Tables 5 List of Figures 6 Introduction 7 Global Markets Direct Report Coverage 7 Post-Operative Pain Overview 8 Therapeutics Development 9 Pipeline Products for Post-Operative Pain - Overview 9 Post-Operative Pain - Therapeutics under Development by Companies 10 Post-Operative Pain - Pipeline Products Glance 13 Late Stage Products 13 Clinical Stage Products 14 Early Stage Products 15 Unknown Stage Products 16 Post-Operative Pain - Products under Development by Companies 17 Post-Operative Pain - Companies Involved in Therapeutics Development 20 AcelRx Pharmaceuticals, Inc. 20 Adynxx, Inc. 21 AngioChem Inc. 22 AskAt Inc. 23 Boehringer Ingelheim GmbH 24 Cara Therapeutics, Inc. 25 Colby Pharmaceutical Company 26 Cytogel Pharma, LLC 27 Dompe Farmaceutici S.p.A. 28 DURECT Corporation 29 Echo Pharmaceuticals B.V. 30 Fujimoto Pharmaceutical Corporation 31 Galleon Pharmaceuticals 32 Grunenthal GmbH 33 GW Pharmaceuticals Plc 34 Heron Therapeutics, Inc. 35 Immupharma Plc 36 Innocoll AG 37 INSYS Therapeutics, Inc. 38 Laboratorios Del Dr. Esteve S.A. 39 Lipocure Ltd. 40 Liquidia Technologies, Inc. 41 Medtronic plc 42 Orbis Biosciences, Inc. 43 Orion Oyj 44 Pacira Pharmaceuticals, Inc. 45 PainReform Ltd. 46 Pharmazz, Inc. 47 PhytoHealth Corporation 48 Proteus SA 49 Recro Pharma, Inc. 50 Relmada Therapeutics, Inc. 51 Serina Therapeutics, Inc. 52 SteadyMed Therapeutics, Inc. 53 Takeda Pharmaceutical Company Limited 54 The Medicines Company 55 Trevena, Inc. 56 Post-Operative Pain - Therapeutics Assessment 57 Assessment by Monotherapy Products 57 Assessment by Combination Products 58 Assessment by Target 59 Assessment by Mechanism of Action 62 Assessment by Route of Administration 65 Assessment by Molecule Type 67 Drug Profiles 69 (bupivacaine hydrochloride + meloxicam) - Drug Profile 69 AM-4 - Drug Profile 71 ANG-2002 - Drug Profile 72 ARX-04 - Drug Profile 73 AYX-1 - Drug Profile 78 BI-1026706 - Drug Profile 80 bupivacaine hydrochloride - Drug Profile 81 bupivacaine hydrochloride - Drug Profile 82 bupivacaine hydrochloride - Drug Profile 83 bupivacaine hydrochloride - Drug Profile 84 bupivacaine hydrochloride ER - Drug Profile 85 bupivacaine hydrochloride SR - Drug Profile 86 buprenorphine hydrochloride - Drug Profile 91 CPC-123 - Drug Profile 92 CR-4056 - Drug Profile 93 Cyt-1010 - Drug Profile 94 dexmedetomidine hydrochloride - Drug Profile 96 DF-2755A - Drug Profile 99 difelikefalin - Drug Profile 100 difluprednate XR - Drug Profile 107 dronabinol - Drug Profile 108 Drug for Post Operative Pain - Drug Profile 110 ECP-1014 - Drug Profile 111 fadolmidine hydrochloride - Drug Profile 112 fentanyl - Drug Profile 113 GAL-044 - Drug Profile 114 grapiprant - Drug Profile 115 IPP-102199 - Drug Profile 117 ketamine hydrochloride - Drug Profile 118 ketorolac tromethamine - Drug Profile 120 levorphanol tartrate ER - Drug Profile 121 MDT-10013 - Drug Profile 123 meloxicam - Drug Profile 124 meloxicam ER - Drug Profile 127 meloxicam ER - Drug Profile 128 MR-309 - Drug Profile 129 nabiximols - Drug Profile 131 nalbuphine hydrochloride - Drug Profile 138 neosaxitoxin - Drug Profile 139 oliceridine - Drug Profile 141 PMZ-2010 - Drug Profile 146 RBM-004 - Drug Profile 147 ropivacaine - Drug Profile 148 ropivacaine ER - Drug Profile 149 SER-226 - Drug Profile 150 Small Molecule for Post-Operative Pain - Drug Profile 151 sufentanil citrate - Drug Profile 152 tapentadol hydrochloride - Drug Profile 160 tramadol hydrochloride - Drug Profile 162 tramadol hydrochloride ER - Drug Profile 163 URB-937 - Drug Profile 164 VVZ-149 - Drug Profile 165 Post-Operative Pain - Dormant Projects 166 Post-Operative Pain - Discontinued Products 171 Post-Operative Pain - Product Development Milestones 172 Featured News & Press Releases 172 Appendix 182 Methodology 182 Coverage 182 Secondary Research 182 Primary Research 182 Expert Panel Validation 182 Contact Us 182 Disclaimer 183
List of Tables
Number of Products under Development for Post-Operative Pain, H2 2016 13 Number of Products under Development by Companies, H2 2016 14 Number of Products under Development by Companies, H2 2016 (Contd..1) 15 Number of Products under Development by Companies, H2 2016 (Contd..2) 16 Comparative Analysis by Late Stage Development, H2 2016 17 Comparative Analysis by Clinical Stage Development, H2 2016 18 Comparative Analysis by Early Stage Development, H2 2016 19 Comparative Analysis by Unknown Stage Development, H2 2016 20 Products under Development by Companies, H2 2016 21 Products under Development by Companies, H2 2016 (Contd..1) 22 Products under Development by Companies, H2 2016 (Contd..2) 23 Post-Operative Pain - Pipeline by AcelRx Pharmaceuticals, Inc., H2 2016 24 Post-Operative Pain - Pipeline by Adynxx, Inc., H2 2016 25 Post-Operative Pain - Pipeline by AngioChem Inc., H2 2016 26 Post-Operative Pain - Pipeline by AskAt Inc., H2 2016 27 Post-Operative Pain - Pipeline by Boehringer Ingelheim GmbH, H2 2016 28 Post-Operative Pain - Pipeline by Cara Therapeutics, Inc., H2 2016 29 Post-Operative Pain - Pipeline by Colby Pharmaceutical Company, H2 2016 30 Post-Operative Pain - Pipeline by Cytogel Pharma, LLC, H2 2016 31 Post-Operative Pain - Pipeline by Dompe Farmaceutici S.p.A., H2 2016 32 Post-Operative Pain - Pipeline by DURECT Corporation, H2 2016 33 Post-Operative Pain - Pipeline by Echo Pharmaceuticals B.V., H2 2016 34 Post-Operative Pain - Pipeline by Fujimoto Pharmaceutical Corporation, H2 2016 35 Post-Operative Pain - Pipeline by Galleon Pharmaceuticals, H2 2016 36 Post-Operative Pain - Pipeline by Grunenthal GmbH, H2 2016 37 Post-Operative Pain - Pipeline by GW Pharmaceuticals Plc, H2 2016 38 Post-Operative Pain - Pipeline by Heron Therapeutics, Inc., H2 2016 39 Post-Operative Pain - Pipeline by Immupharma Plc, H2 2016 40 Post-Operative Pain - Pipeline by Innocoll AG, H2 2016 41 Post-Operative Pain - Pipeline by INSYS Therapeutics, Inc., H2 2016 42 Post-Operative Pain - Pipeline by Laboratorios Del Dr. Esteve S.A., H2 2016 43 Post-Operative Pain - Pipeline by Lipocure Ltd., H2 2016 44 Post-Operative Pain - Pipeline by Liquidia Technologies, Inc., H2 2016 45 Post-Operative Pain - Pipeline by Medtronic plc, H2 2016 46 Post-Operative Pain - Pipeline by Orbis Biosciences, Inc., H2 2016 47 Post-Operative Pain - Pipeline by Orion Oyj, H2 2016 48 Post-Operative Pain - Pipeline by Pacira Pharmaceuticals, Inc., H2 2016 49 Post-Operative Pain - Pipeline by PainReform Ltd., H2 2016 50 Post-Operative Pain - Pipeline by Pharmazz, Inc., H2 2016 51 Post-Operative Pain - Pipeline by PhytoHealth Corporation, H2 2016 52 Post-Operative Pain - Pipeline by Proteus SA, H2 2016 53 Post-Operative Pain - Pipeline by Recro Pharma, Inc., H2 2016 54 Post-Operative Pain - Pipeline by Relmada Therapeutics, Inc., H2 2016 55 Post-Operative Pain - Pipeline by Serina Therapeutics, Inc., H2 2016 56 Post-Operative Pain - Pipeline by SteadyMed Therapeutics, Inc., H2 2016 57 Post-Operative Pain - Pipeline by Takeda Pharmaceutical Company Limited, H2 2016 58 Post-Operative Pain - Pipeline by The Medicines Company, H2 2016 59 Post-Operative Pain - Pipeline by Trevena, Inc., H2 2016 60 Assessment by Monotherapy Products, H2 2016 61 Assessment by Combination Products, H2 2016 62 Number of Products by Stage and Target, H2 2016 64 Number of Products by Stage and Mechanism of Action, H2 2016 67 Number of Products by Stage and Route of Administration, H2 2016 70 Number of Products by Stage and Molecule Type, H2 2016 72 Post-Operative Pain - Dormant Projects, H2 2016 170 Post-Operative Pain - Dormant Projects (Contd..1), H2 2016 171 Post-Operative Pain - Dormant Projects (Contd..2), H2 2016 172 Post-Operative Pain - Dormant Projects (Contd..3), H2 2016 173 Post-Operative Pain - Dormant Projects (Contd..4), H2 2016 174 Post-Operative Pain - Discontinued Products, H2 2016 175



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $2000
Multi User - US $4000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify